CN Patent

CN105121404A — 作为RORc调节剂的芳基磺酰胺和氨基磺酸衍生物

Assigned to F Hoffmann La Roche AG · Expires 2015-12-02 · 10y expired

What this patent protects

式I化合物或其可药用盐，其中m、n、p、q、r、A、X 1 、X 2 、X 3 、X 4 、X 5 、X 6 、Y、Z、G、R 1a 、R 2a 、R 1b 、R 2b 、R 3 、R 4 、R 5 和R 6 如本文所定义。还公开了制备所述化合物的方法和采用所述化合物来治疗炎性疾病如关节炎的方法。

USPTO Abstract

式I化合物或其可药用盐，其中m、n、p、q、r、A、X 1 、X 2 、X 3 、X 4 、X 5 、X 6 、Y、Z、G、R 1a 、R 2a 、R 1b 、R 2b 、R 3 、R 4 、R 5 和R 6 如本文所定义。还公开了制备所述化合物的方法和采用所述化合物来治疗炎性疾病如关节炎的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN105121404A
Jurisdiction
CN
Classification
—
Expires
2015-12-02
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.